title: Intracellular injection of heparin and polyamines. Effects on phototransduction in limulus ventral photoreceptors.
abstract: Heparin is thought to inhibit InsP3 binding to receptors involved in the intracellular release of Ca2+. Injection of heparin into Limulus ventral photoreceptors to high intracellular concentrations reduces the amplitude and slows the rate of rise of voltage-clamp currents induced by brief flashes, tends to make the responses to long flashes more "square," and tends to block the light-induced rise in [Ca2+]i detected by arsenazo III. In these ways, intracellular heparin mimics the effects of high concentrations of intracellular BAPTA or EGTA. In addition, the effects of heparin are attenuated by prior injection of BAPTA to high intracellular concentrations. Neomycin and spermine are thought to inhibit phospholipase C activity. Injections of spermine or neomycin to low intracellular concentrations largely mimic the effects of intracellular heparin. These findings suggest that the predominant effect of polyamines is to inhibit light-induced production of InsP3 by phospholipase C activity and thereby reduce the light-induced increase in [Ca2+]i. Our findings suggest that excitation can proceed in the absence of InsP3-induced increases in [Ca2+]i, but (a) the gain and speed of transduction are reduced and (b) adaptation is largely blocked.
authors.affiliation: Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri 63110.
authors.forename: M N
authors.initials: MN
authors.lastname: Faddis
authors.forename: J E
authors.initials: JE
authors.lastname: Brown
mesh_terms: D000200:Action Potentials / Q000502:physiology; D000818:Animals; D001150:Arsenazo III; D002118:Calcium / Q000032:analysis / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004533:Egtazic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D006493:Heparin / Q000008:administration & dosage / Q000494:pharmacology*; D006737:Horseshoe Crabs / Q000502:physiology*; D015544:Inositol 1,4,5-Trisphosphate / Q000494:pharmacology; D008027:Light; D008839:Microelectrodes; D008845:Microinjections; D009355:Neomycin / Q000494:pharmacology; D010786:Photoreceptor Cells / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D011073:Polyamines / Q000008:administration & dosage / Q000494:pharmacology*; D013096:Spermine / Q000494:pharmacology; D010738:Type C Phospholipases / Q000502:physiology
chemical_list: D011073:Polyamines; D001150:Arsenazo III; D013096:Spermine; D004533:Egtazic Acid; D015544:Inositol 1,4,5-Trisphosphate; D006493:Heparin; D010738:Type C Phospholipases; D009355:Neomycin; C025603:1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid; D002118:Calcium